New Product

PRI-BUQUONE INJECTION

Registered veterinary formulation (DRAP Reg: 122976)

Active: (BP SPECIFICATIONS); EACH ML CONTAINS:-; BUPARVAQUONE----50MG; AS PER INNOVATOR''S SPECIFICATION; EACH ML CONTAINS:-; TRIMETHOPRIM----80MG

PRI-BUQUONE INJECTION is a verified injection developed and manufactured by Prix Pharmaceutica Pvt Ltd under strict cGMP protocols. Formulated for Livestock to provide consistent therapeutic efficacy and safety.

livestockinjectable

Withdrawal period: Milk: 48 hours. Meat: 42 days.

Compare

Marketed by Prix Pharmaceutica (Pvt) Ltd.

Overview

Administration Route

As directed on approved label

Dosage Form

injectable

Composition

Active Ingredient	Strength / Quantity
BUPARVAQUONE	50MG
TRIMETHOPRIM	80MG

Indications

Pri-Buquone is recommended for the treatment of Theileriosis (T. Anulata, T. Parva, T. Mutans, T. Orientalis sergenti) in cattle It is active against both schizont/ piroplasma stages of Theileria when used in incubation or on appearance of sign symptoms of active disease.

Dosage & Administration

Intra-muscular (IM). Cattle (cow, buffalo), sheep, goat: 1 ml per 20 kg body weight, maximum 30 ml at one site of injection. In severe onset of disease dose may be given within 48-72 hours.

Always use under the guidance of a qualified veterinary professional.

Warnings & Precautions

For veterinary use only. Not for human use. Keep out of reach of children.

Withdrawal Period

Milk: 48 hours. Meat: 42 days.

Storage Instructions

Store below 25°C protected from direct sunlight

Packing

20ML

Target species

Livestock

Product Documents

Contact Prix Pharmaceutica (Pvt) Ltd. for approved product literature and documentation.

⚠️ Safety Notice

For veterinary use only. Use according to approved product literature and under the guidance of a qualified veterinary professional.

Need guidance?

Our technical team can assist with product selection, dosage and programme development.

Technical Support 📞 +92 42 36283464

Product Specifications

Product ID: PRX-NEW-085
Life Stages: Adult, Young stock
Manufacturing: Marketed by Prix Pharmaceutica (Pvt) Ltd.

Report a product complaint Report an adverse event

Responsible veterinary use

Product information is provided for professional veterinary reference. Follow the approved product label and consult a qualified veterinarian where appropriate.

Contact Prix Pharmacovigilance Product complaint

Frequently asked questions about PRI-BUQUONE INJECTION

Answers below reflect catalogue information only. Always follow the approved product label and qualified veterinary guidance.

What is PRI-BUQUONE INJECTION?

Which dosage form is available for PRI-BUQUONE INJECTION?

PRI-BUQUONE INJECTION is listed as injection. Always confirm the presentation on the approved product label before use.

Which pack sizes are listed for PRI-BUQUONE INJECTION?

Listed pack sizes include: 20ML (PRX-NEW-085). Availability may vary by region and distributor.

Which animal category is PRI-BUQUONE INJECTION listed under?

PRI-BUQUONE INJECTION is listed under Livestock in the Prix Pharmaceutica product catalogue.

Where can product information for PRI-BUQUONE INJECTION be requested?

Use the Product Inquiry form on this page, or contact Prix Pharmaceutica via the Contact page. You may also request literature through the document request option where available.

How should the approved product label be followed?

Products must be used according to the approved product label and under qualified veterinary guidance. Website information does not replace approved labelling or professional advice.

Who should be consulted before veterinary use?

Consult a qualified veterinarian before using any veterinary pharmaceutical or nutritional product. Prix Pharmaceutica can help with product information requests through Contact or Product Inquiry.